288 related articles for article (PubMed ID: 21724411)
1. Extra-thymically induced regulatory T cells: do they have potential in disease prevention?
Daniel C; von Boehmer H
Semin Immunol; 2011 Dec; 23(6):410-7. PubMed ID: 21724411
[TBL] [Abstract][Full Text] [Related]
2. Extrathymic generation of regulatory T cells--chances and challenges for prevention of autoimmune disease.
Daniel C; von Boehmer H
Adv Immunol; 2011; 112():177-213. PubMed ID: 22118409
[TBL] [Abstract][Full Text] [Related]
3. Peripherally induced Treg: mode, stability, and role in specific tolerance.
Apostolou I; Verginis P; Kretschmer K; Polansky J; Hühn J; von Boehmer H
J Clin Immunol; 2008 Nov; 28(6):619-24. PubMed ID: 18841451
[TBL] [Abstract][Full Text] [Related]
4. Type 1 diabetes vaccine candidates promote human Foxp3(+)Treg induction in humanized mice.
Serr I; Fürst RW; Achenbach P; Scherm MG; Gökmen F; Haupt F; Sedlmeier EM; Knopff A; Shultz L; Willis RA; Ziegler AG; Daniel C
Nat Commun; 2016 Mar; 7():10991. PubMed ID: 26975663
[TBL] [Abstract][Full Text] [Related]
5. Thymic commitment of regulatory T cells is a pathway of TCR-dependent selection that isolates repertoires undergoing positive or negative selection.
Coutinho A; Caramalho I; Seixas E; Demengeot J
Curr Top Microbiol Immunol; 2005; 293():43-71. PubMed ID: 15981475
[TBL] [Abstract][Full Text] [Related]
6. Restoring self-tolerance in autoimmune diseases by enhancing regulatory T-cells.
Kumar P; Saini S; Khan S; Surendra Lele S; Prabhakar BS
Cell Immunol; 2019 May; 339():41-49. PubMed ID: 30482489
[TBL] [Abstract][Full Text] [Related]
7. Instruction of Treg commitment in peripheral T cells is suited to reverse autoimmunity.
Jaeckel E; Kretschmer K; Apostolou I; von Boehmer H
Semin Immunol; 2006 Apr; 18(2):89-92. PubMed ID: 16473523
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of self-nonself discrimination and possible clinical relevance.
Daniel C; Nolting J; von Boehmer H
Immunotherapy; 2009 Jul; 1(4):631-44. PubMed ID: 20582233
[TBL] [Abstract][Full Text] [Related]
9. A self-reactive TCR drives the development of Foxp3+ regulatory T cells that prevent autoimmune disease.
Killebrew JR; Perdue N; Kwan A; Thornton AM; Shevach EM; Campbell DJ
J Immunol; 2011 Jul; 187(2):861-9. PubMed ID: 21690323
[TBL] [Abstract][Full Text] [Related]
10. Making regulatory T cells with defined antigen specificity: role in autoimmunity and cancer.
Kretschmer K; Apostolou I; Jaeckel E; Khazaie K; von Boehmer H
Immunol Rev; 2006 Aug; 212():163-9. PubMed ID: 16903913
[TBL] [Abstract][Full Text] [Related]
11. Targeted antigen delivery to DEC-205⁺ dendritic cells for tolerogenic vaccination.
Petzold C; Schallenberg S; Stern JN; Kretschmer K
Rev Diabet Stud; 2012; 9(4):305-18. PubMed ID: 23804268
[TBL] [Abstract][Full Text] [Related]
12. Treg vaccination in autoimmune type 1 diabetes.
Serr I; Weigmann B; Franke RK; Daniel C
BioDrugs; 2014 Feb; 28(1):7-16. PubMed ID: 23959795
[TBL] [Abstract][Full Text] [Related]
13. CD4+Foxp3+ regulatory T cells in the control of autoimmunity: in vivo veritas.
Piccirillo CA; d'Hennezel E; Sgouroudis E; Yurchenko E
Curr Opin Immunol; 2008 Dec; 20(6):655-62. PubMed ID: 18926906
[TBL] [Abstract][Full Text] [Related]
14. Low-Zone IL-2 Signaling: Fusion Proteins Containing Linked CD25 and IL-2 Domains Sustain Tolerogenic Vaccination
DeOca KB; Moorman CD; Garcia BL; Mannie MD
Front Immunol; 2020; 11():541619. PubMed ID: 33072087
[TBL] [Abstract][Full Text] [Related]
15. Extra-thymically induced T regulatory cell subsets: the optimal target for antigen-specific immunotherapy.
Verhagen J; Wegner A; Wraith DC
Immunology; 2015 Jun; 145(2):171-81. PubMed ID: 25716063
[TBL] [Abstract][Full Text] [Related]
16. Regulatory T cells and antigen-specific tolerance.
Kretschmer K; Apostolou I; Verginis P; von Boehmer H
Chem Immunol Allergy; 2008; 94():8-15. PubMed ID: 18802332
[TBL] [Abstract][Full Text] [Related]
17. Regulatory T cells and immune tolerance.
Sakaguchi S; Yamaguchi T; Nomura T; Ono M
Cell; 2008 May; 133(5):775-87. PubMed ID: 18510923
[TBL] [Abstract][Full Text] [Related]
18. Treg Enhancing Therapies to Treat Autoimmune Diseases.
Eggenhuizen PJ; Ng BH; Ooi JD
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32977677
[TBL] [Abstract][Full Text] [Related]
19. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease.
Sakaguchi S; Ono M; Setoguchi R; Yagi H; Hori S; Fehervari Z; Shimizu J; Takahashi T; Nomura T
Immunol Rev; 2006 Aug; 212():8-27. PubMed ID: 16903903
[TBL] [Abstract][Full Text] [Related]
20. A GMCSF-Neuroantigen Tolerogenic Vaccine Elicits Systemic Lymphocytosis of CD4
Moorman CD; Curtis AD; Bastian AG; Elliott SE; Mannie MD
Front Immunol; 2018; 9():3119. PubMed ID: 30687323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
